Disease Treatment Applications

Periodontics

Dental laser treatment for periodontal disease was one of the first reasons why the ...

By PIOON based in Wuhan, CHINA.

Ventilators for Heliox Ventilation

treatment for cardiopulmonary disease in 1935. Although the medical community adopted its use ...

By eVent Medical based in Lake Forest, CALIFORNIA (USA).

Plasmatherapies

a large number of diseases. ...

By Infomed SA based in Meinier, SWITZERLAND.

Medical Devices for Severe or Advanced Stage Heart Failure Treatment

the disease. Heart Transplant & Ventricular Assist Devices are included in this category. These ...

By Impulse Dynamics based in Marlton, NEW JERSEY (USA).

Targeted genetic sequencing solutions for diabetes sector

1 in 10 American have diabetes. Over 88 million Americans are pre-diabetic. Tesis Biosciences is working with physicians and research organizations to reverse this epidemic by helping to identify people with prediabetes, predict likelihood of diabetes to help prevent type 2 diabetes, identify and prevent diabetes complications, and improve the health of all people with diabetes. ...

By Tesis Biosciences based in Scottsdale, ARIZONA (USA).

Venous Stent System for Clinical Trial

The VIVID clinical trial is currently recruiting adult patients that have Chronic Venous Insufficiency (CVI) and are eligible for a venous stent in their iliac or common femoral ...

By Vesper Medical, Inc. based in Wayne, PENNSYLVANIA (USA).

Patient-reported outcomes in orthopedics sector

. Assessing the impact of disease and treatment on health-related quality of life is increasingly ...

By Heartbeat Medical based in Berlin, GERMANY.

Patient-reported outcomes in oncology sector

Monitor quality of life and treatment effects to increase overall wellbeing. PROMs have ...

By Heartbeat Medical based in Berlin, GERMANY.

Patient-Reported outcomes in cardiology sector

the treatment of chronic conditions. ...

By Heartbeat Medical based in Berlin, GERMANY.

Software Solutions for COVID-19

As the COVID-19 pandemic continues, the SARS-CoV-2 virus is likely to become endemic with emerging novel variants, some of them seasonal. Updates to the various vaccines will be required, as will a range of anti-virals with a variety of mechanisms of action, for use in early infection and in hospitalizated patients, much like oseltamivir (Tamiflu) is used in certain populations for seasonal ...

By Cyrus Biotechnology Inc. based in Seattle, WASHINGTON (USA).

Shielded Living Therapeutics Cell for Lysosomal Diseases

diseases have no FDA-approved ...

By Sigilon Therapeutics, Inc. based in Cambridge, MASSACHUSETTS (USA).

RNA Technology for Clinical trials

Our collective health depends on finding new vaccines and treatments for diseases and ...

By Moderna, Inc. based in Cambridge, MASSACHUSETTS (USA).

Solution for Access to Investigational Medicines

to their loved ones, disease-free. In order to bring new treatments to patients, we conduct clinical ...

By Zymeworks Inc based in Vancouver, BRITISH COLUMBIA (CANADA).

Software Solution for Healthcare Provider

Automated MRI analyses that may help inform earlier, more accurate viewsof CNS ...

By Qynapse based in Paris, FRANCE.

Microbiome Therapeutics for Clinical Trials

Finch’s lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection (CDI), and has received Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration. In June 2020, Finch announced that CP101 met its primary efficacy endpoint in PRISM3, the first of two pivotal trials to support the development of CP101 for the prevention of recurrent CDI. PRISM4, a Phase 3 trial, is designed to serve as the second pivotal trial of ...

By Finch Therapeutics Group, Inc. based in Somerville, MASSACHUSETTS (USA).